Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 152
Filter
2.
J Thorac Cardiovasc Surg ; 122(4): 699-705, 2001 Oct.
Article in English | MEDLINE | ID: mdl-11581601

ABSTRACT

OBJECTIVES: Bone marrow stromal cells contain "adult stem cells." We tested the hypothesis that coronary-infused bone marrow stromal cells may populate the infarcted heart and undergo milieu-dependent differentiation to regenerate functional tissues with different phenotypic features. METHODS: Isogenic adult rats were used as donors and recipients to simulate autologous transplantation clinically. Myocardial infarction was created by proximal occlusion of left coronary artery in 12 recipient rats. Isolated bone marrow stromal cells were purified, expanded, and retrovirally transduced with LacZ reporter gene for cell labeling. Stromal cells were then infused into the briefly distally clamped ascending aorta of recipient rats 2 weeks after left coronary artery ligation. The hearts were harvested immediately (n = 2) or 4 weeks (n = 10) later to trace the implanted cells and identify their phenotypes. RESULTS: Viable cells labeled with LacZ reporter gene were identified in 8 recipient hearts. Immediately after cell infusion, the labeled cells were trapped within the coronary capillaries. After 4 weeks, they could be detected individually or in clusters within myocardial scar expressing fibroblastic phenotype or outside the infarction area with morphologic features of normal cardiomyocytes. Some were incorporated into endocardium and capillary endothelium. CONCLUSIONS: Our findings suggest that bone marrow stromal cells can traffic through the coronary system to the injured heart and form cardiomyocytes or fibroblasts, depending on the specific microenvironment. Endothelial progenitor cells in the stromal cell population may be involved in the postinfarction neovascularization process. Whether therapeutic use of bone marrow stromal cells can improve the myocardial healing and remodeling process after infarction is worthy of further investigation.


Subject(s)
Bone Marrow Cells , Myocardial Infarction/therapy , Stromal Cells , Animals , Cells, Cultured , Coronary Vessels , Infusions, Intra-Arterial , Male , Myocardial Infarction/physiopathology , Rats , Rats, Inbred Lew , Regeneration
3.
ASAIO J ; 47(1): 50-5, 2001.
Article in English | MEDLINE | ID: mdl-11199315

ABSTRACT

The LD-PACE II was designed for use in cardiomyoplasty, aortomyoplasty, and skeletal muscle ventricles. All parameters specified as programmable can be changed in a noninvasive manner (using a programming interface wand connected to a computer using the Windows 95/98 environment). Two new functions may be very useful clinically, based on experimental research. 1. Work-rest regimen. The LD-PACE II is able to deliver alternating periods of muscle contractions and rest. Work and rest periods may be programmed independently between 1 and 120 minutes in increments of 1 minute. The work-rest regimen may be useful clinically if muscle contractions are needed for cardiac assist postoperatively. 2. Night/day regimen. This feature allows for a change in the ratio of muscle contractions according to a patient's activity level. During the day the cardiosynchronization ratio may be set from 1:1 to 1:4, and during the night it may be set for 1:8 to 1:16. This allows the muscle to have a long rest period, prevents overuse, and prolongs battery life. These two new features make this cardiomyostimulator very attractive for cardiomyoplasty in particular. The addition of the work-rest and night-day regimens allow the muscle to rest for periods during the day to prevent overuse, subsequent damage, and potential atrophy.


Subject(s)
Cardiomyoplasty/instrumentation , Heart-Assist Devices , Heart/physiology , Pacemaker, Artificial , Humans , Myocardial Contraction , Prosthesis Design
4.
J Thorac Cardiovasc Surg ; 120(5): 999-1005, 2000 Nov.
Article in English | MEDLINE | ID: mdl-11044327

ABSTRACT

OBJECTIVES: Marrow stromal cells are mesenchymal stem cells able to differentiate into cardiomyocytes in vitro. We tested the hypothesis that marrow stromal cells, when implanted into myocardium, can undergo milieu-dependent differentiation and express cardiomyogenic phenotypes in vivo. METHODS: Isogenic adult rats were used as donors and recipients to simulate autologous transplantation. Marrow stromal cells isolated from donor leg bones were culture-expanded, labeled with 4;,6-diamidino-2-phenylindole, and then injected into the myocardium of the recipients. The hearts were harvested from 4 days to 12 weeks after implantation, and the implant sites were examined to identify the phenotypes of the labeled marrow stromal cells. RESULTS: Viable cells labeled with 4;, 6-diamidino-2-phenylindole can be identified in host myocardium at all time points after implantation. Implanted marrow stromal cells show the growth potential in a myocardial environment. After 4 weeks, donor cells derived from marrow stromal cells demonstrate myogenic differentiation with the expression of sarcomeric myosin heavy chain and organized contractile proteins. Positive staining for connexin 43 indicates the formation of gap junctions, which suggests that cells derived from marrow stromal cells, as well as native cardiomyocytes, are connected by intercalated disks. CONCLUSIONS: Different cell sources have been used as donor cells for cellular cardiomyoplasty. Our findings indicate that marrow stromal cells can also be used as donor cells. In an appropriate microenvironment they will exhibit cardiomyogenic phenotypes and may replace native cardiomyocytes lost by necrosis or apoptosis. Because marrow stromal cells can be obtained repeatedly by bone marrow aspiration and expanded vastly in vitro before being implanted or used as autologous implants, and because their use does not call for immunosuppression, the clinical use of marrow stromal cells for cellular cardiomyoplasty appears to be most advantageous.


Subject(s)
Hematopoietic Stem Cell Transplantation , Myocardium/cytology , Animals , Cell Differentiation , Cells, Cultured , Feasibility Studies , Immunohistochemistry , Male , Phenotype , Rats , Rats, Inbred Lew , Staining and Labeling/methods , Transplantation, Autologous
6.
J Thorac Cardiovasc Surg ; 118(5): 849-56, 1999 Nov.
Article in English | MEDLINE | ID: mdl-10534690

ABSTRACT

BACKGROUND: Angiogenesis is the proposed mechanism of transmyocardial revascularization. We evaluated mechanical transmyocardial revascularization in a chronically ischemic porcine model by measuring myocardial angiogenic response. METHODS: Ameroid constrictors were implanted 6 weeks before mechanical transmyocardial revascularization. Group I (n = 5) and group II (n = 3) animals received 30 punctures with an 18-gauge needle and samples were harvested at 1 and 4 weeks, respectively, after the operation. Group III (n = 5) had sternotomy only and served as the control group. Myocardial samples were immunohistochemically stained for vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF), and transforming growth factor beta (TGF-beta) using specific antibodies. Growth factor expression was quantified by means of computer-assisted morphometry. Vascular density was assessed by immunohistochemical stain for VEGF and factor VIII. RESULTS: Compared with group III, increased angiogenic factor levels were found in group I (VEGF 0.47 +/- 0.03 mm(2) vs 0.05 +/- 0.05 mm(2), P =.000; bFGF 0.67 +/- 0.14 mm(2) vs 0.03 +/- 0.03 mm(2), P =. 000; TGF-beta 1.40 +/- 0.18 mm(2) vs 0.09 +/- 0.06 mm(2), P = 0.000), and in group II (VEGF 0.34 +/- 0.06 mm(2) vs 0.05 +/- 0.05 mm(2), P =.003; bFGF 0.06 +/- 0.02 mm(2) vs 0.03 +/- 0.03 mm(2), P =.135; TGF-beta 0.28 +/- 0.09 mm(2) vs 0.09 +/- 0.06 mm(2), P =.042). Vascular densities after mechanical transmyocardial revascularization were also increased (group I, VEGF stain 8.1 +/- 0. 6 vs 1.1 +/- 0.5, P =.000; factor VIII stain 5.1 +/- 2.7 vs 0.4 +/- 0.3, P =.018; group II, VEGF stain 1.9 +/- 0.5 vs 1.1 +/- 0.5, P = 0. 107; factor VIII stain 2.3 +/- 0.4 vs 0.4 +/- 0.3, P =.004). CONCLUSIONS: Mechanical transmyocardial revascularization is associated with increased angiogenic factor expression and concomitant neovascularization at up to 4 weeks. These changes are indistinguishable from those of laser transmyocardial revascularization. Myocardial perfusion studies are needed to establish the functional significance of these angiogenic changes.


Subject(s)
Myocardial Revascularization/methods , Neovascularization, Physiologic , Animals , Endothelial Growth Factors/biosynthesis , Fibroblast Growth Factor 2/biosynthesis , Lymphokines/biosynthesis , Myocardial Ischemia/etiology , Myocardial Ischemia/surgery , Myocardium/metabolism , Needles , Protein Isoforms/biosynthesis , Punctures , Swine , Time Factors , Transforming Growth Factor beta/biosynthesis , Vascular Endothelial Growth Factor A , Vascular Endothelial Growth Factors
7.
Ann Thorac Surg ; 68(2): 301-7; discussion 307-8, 1999 Aug.
Article in English | MEDLINE | ID: mdl-10475386

ABSTRACT

BACKGROUND: Transmyocardial laser revascularization (TMLR), which has been shown to reduce angina in clinical trials, was originally based on the belief that laser channels are unique and can remain patent. An increasing body of evidence indicates otherwise, and transmyocardial revascularization (TMR) angiogenesis is currently thought to be induced by nonspecific inflammatory response to tissue injuries. We tested the hypothesis that mechanical transmyocardial revascularization (TMMR) may induce angiogenic responses similar to that seen with lasers. METHODS: Ameroid constrictors were implanted around proximal circumflex arteries of porcine hearts. Six weeks later, they were randomly assigned (n = 5 each) to receive 10 transmural channels in the ischemic zone by a carbon dioxide laser (group I) or by a needle (group II). A third group (group III) had 30 needle channels in the same area, while a control group (group IV) received no TMR. The hearts were harvested 1 week later, and, using immunohistochemistry, vascular endothelial growth factor (VEGF) expression was studied and quantified by computerized morphometric analysis. Densities of vascular structures positively stained for VEGF per high-power field (HPF) were also compared. RESULTS: Virtually no TMR channels remained patent histologically. Group III had a significant higher level of total VEGF expression (14.18+/-0.78 mm2) compared with group I (7.07+/-2.06 mm2, p < 0.001) and group II (4.74+/-3.35 mm2, p < 0.001). Vascular density was significantly elevated in all treatment groups compared with the control (group I, 7.7+/-0.8/HPF vs group II, 4.5+/-2.3/HPF vs group III, 8.1+/-0.6/HPF vs group IV, 1.1+/-0.5/HPF). CONCLUSIONS: In view of the significant cost implications, our findings that needle punctures may also induce angiogenic response comparable with that with laser suggest that it is justifiable and desirable to include a TMMR arm for comparison with TMLR in future clinical trials.


Subject(s)
Coronary Circulation/physiology , Coronary Disease/surgery , Laser Therapy/instrumentation , Myocardial Revascularization/instrumentation , Neovascularization, Physiologic/physiology , Punctures/instrumentation , Animals , Coronary Disease/pathology , Coronary Disease/physiopathology , Coronary Vessels/pathology , Coronary Vessels/physiopathology , Endothelial Growth Factors/analysis , Image Processing, Computer-Assisted , Lymphokines/analysis , Myocardium/pathology , Outcome and Process Assessment, Health Care , Swine , Vascular Endothelial Growth Factor A , Vascular Endothelial Growth Factors
8.
J Formos Med Assoc ; 98(5): 301-8, 1999 May.
Article in English | MEDLINE | ID: mdl-10420696

ABSTRACT

Transmyocardial revascularization (TMR) is a new surgical procedure aimed at increasing blood flow to the ischemic myocardium. It has been used for treatment of patients with end-stage coronary artery disease who are not candidates for conventional measures such as medication, percutaneous transluminal coronary angioplasty, and coronary artery bypass grafting. TMR involves creating transmural channels in the myocardium using lasers, in areas shown to be ischemic during preoperative testing. This procedure has shown promising results in clinical trials, but the mechanism of its efficacy remains largely unknown. TMR was originally developed as a means of supplying blood to the ventricular myocardium, directly through channels made in the wall of the ventricle. This was in an attempt to recreate the situation that exists in the reptilian heart, in which the myocardium is perfused directly from the ventricular chamber through a rich network of sinusoids that bathe the myocardial cells. However, the existence of a significant sinusoidal network in the human heart is doubtful. Whether the myocardium can be perfused directly via the TMR channels is controversial; it is becoming clear that other mechanisms such as angiogenesis are also at work. This review will use TMR as an example to illustrate how surgical practice and thinking can be based on theories that have little or no sound experimental evidence to support them. The importance of elucidating the valid scientific basis of surgical procedures in this modern era of evidence-based medicine will be emphasized.


Subject(s)
Myocardial Revascularization/methods , Coronary Circulation , Denervation , History, 20th Century , Humans , Laser Therapy , Myocardial Revascularization/history , Neovascularization, Physiologic , Vascular Patency
9.
J Thorac Cardiovasc Surg ; 116(5): 744-51, 1998 Nov.
Article in English | MEDLINE | ID: mdl-9806381

ABSTRACT

OBJECTIVE: Implanting myoblasts derived from autologous skeletal muscle, that is, satellite cells, for myocardial replacement has many advantages when compared with implanting either fetal cardiac myocytes (ethical and donor availability issues) or established cell lines (oncogenicity). Furthermore, autologous myoblasts do not require immunosuppression. The feasibility of satellite cell differentiation into muscle fibers, after implantation into the myocardium, was confirmed by means of a unique cell-labeling technique. METHODS: Myoblasts (satellite cells) isolated from the skeletal muscle of adult rats are labeled with 4',6-diamidino-2-phenylindone, which binds to DNA and to the protein tubulin to form a fluorescent complex, and implanted into the left ventricular wall of isogenic rats. The specimens are harvested 1 to 4 weeks after myoblast implantation. Histologic sections are examined under a fluorescent microscope. RESULTS: The labeling efficiency of satellite cells with 4',6-diamidino-2-phenylindole is nearly 100%. In 4 specimens, the progressive differentiation of implanted myoblasts into fully developed striated muscle fibers can be observed. CONCLUSION: Our earlier studies of autologous myoblast implantation into the cryoinjured myocardium of dogs suggested that these cells could differentiate into cardiac myocytes. However, it had been difficult to firmly establish these findings with the use of cell markers, thereby proving that the neomyocardium had indeed been derived from the implanted myoblasts. In this study, using 4',6-diamidino-2-phenylindole as a satellite cell marker, we were able to demonstrate that the implanted satellite cells did in fact differentiate into fully developed, labeled muscle fibers. Because of the obvious advantages of using autologous donor myoblasts, the clinical application of this approach may provide a novel strategy for the future management of heart failure.


Subject(s)
Cell Differentiation/physiology , Muscle, Skeletal/transplantation , Myocardium/pathology , Regeneration/physiology , Animals , Dogs , Male , Microscopy, Fluorescence , Rats , Rats, Inbred Lew , Transplantation, Autologous , Transplantation, Isogeneic
10.
Ann Thorac Surg ; 66(1): 12-8, 1998 Jul.
Article in English | MEDLINE | ID: mdl-9692432

ABSTRACT

BACKGROUND: The mechanism by which transmyocardial revascularization (TMR) exerts a beneficial effect remains unknown. We hypothesize that the myocardial punctures of TMR cause a myocardial injury, leading to an angiogenic response mediated by a number of growth factors. METHODS: Fifty-three rats underwent ligation of the left coronary artery. Group I (n = 25) served as controls, whereas group II (n = 28) underwent concomitant TMR by the creation of six transmural channels with a 25-gauge needle in the ischemic zone. Surviving animals in both groups were sacrificed at intervals of 1, 2, 4, and 8 weeks (n = 5 in each subgroup). Immunohistochemistry in the infarct areas was performed for factor VIII to assess vascular density. Immunohistochemistry using specific antibodies was also performed for transforming growth factor-beta, basic-fibroblast growth factor, and vasoendothelial growth factor. Growth factor expression was quantitated by comparing areas of staining (in mm2) with computerized morphometric analysis. RESULTS: Mortality was similar in both groups (5/25 versus 8/28; not significant). Group II had significantly greater vascular density than group I (5.65 versus 4.06 vessels/high-power field; p < 0.001), with a peak at 1 week postoperatively (9.12 versus 5.56 vessels/high-power field; p < 0.0001) in both groups. Overall, levels of both transforming growth factor-beta and basic-fibroblast growth factor were significantly higher in the TMR group compared with the control group (0.207 versus 0.141 mm2/mm2, p < 0.05; and 0.125 versus 0.099 mm2/ mm2, p < 0.05). CONCLUSIONS: This model of TMR is associated with a significant angiogenic response, which appears to be mediated by the release of certain angiogenic growth factors such as transforming growth factor-beta and basic-fibroblast growth factor. With the long-term patency of laser-created myocardial channels in clinical TMR increasingly in doubt, its mechanism of myocardial revascularization may be similar to that observed in our model.


Subject(s)
Endothelial Growth Factors/analysis , Fibroblast Growth Factor 2/analysis , Lymphokines/analysis , Myocardial Revascularization/methods , Neovascularization, Physiologic/physiology , Transforming Growth Factor beta/analysis , Animals , Coloring Agents , Coronary Vessels/pathology , Disease Models, Animal , Endothelial Growth Factors/genetics , Factor VIII/analysis , Fibroblast Growth Factor 2/genetics , Follow-Up Studies , Gene Expression Regulation , Image Processing, Computer-Assisted , Immunohistochemistry , Laser Therapy/methods , Lymphokines/genetics , Male , Myocardial Ischemia/surgery , Needles , Rats , Rats, Inbred Lew , Survival Rate , Transforming Growth Factor beta/genetics , Vascular Endothelial Growth Factor A , Vascular Endothelial Growth Factors , Vascular Patency
11.
J Thorac Cardiovasc Surg ; 116(1): 148-53, 1998 Jul.
Article in English | MEDLINE | ID: mdl-9671909

ABSTRACT

OBJECTIVE: Because adynamic cardiomyoplasty, or wrapping skeletal muscle around the heart, had been shown to provide a girdling effect and delay progressive ventricular dilatation in heart failure, a similar girdling effect by the much simpler procedure of cardiac binding, using a prosthetic membrane to wrap the heart, was studied and compared with that of adynamic cardiomyoplasty. METHODS: Twenty-one dogs were divided into control, adynamic cardiomyoplasty, and cardiac binding groups. Cardiac dimension and hemodynamic studies were carried out before and 4 weeks after rapid pacing at 250 beats/min. For adynamic cardiomyoplasty, the left latissimus dorsi muscle was used for the cardiac wrap; for cardiac binding, a Marlex sheet (C. R. Bard, Inc., Murray Hill, N.J.) was used. Serial two-dimensional echocardiography, right heart catheterization, and in the cardiac binding group, left heart catheterization were performed. RESULTS: Four weeks of rapid pacing induced severe heart failure and cardiac dilatation. The magnitude of ventricular dilatation at the end of rapid pacing was less in the cardiac binding group than in the control group and least in the adynamic cardiomyoplasty group. Left ventricular end-diastolic volume, end-systolic volume, and ejection fraction were 82.1 +/- 21.1 ml, 67.1 +/- 16.0 ml, and 17.5% +/- 5.8%, respectively, in the control group; 61.9. +/- 8.1 ml, 44.1 +/- 7.8 ml, and 30.1% +/- 3.6%, respectively, in the cardiac binding group; and 51.8 +/- 8.7 ml, 30.3 +/- 10.4 ml, and 27.0% +/- 4.0%, respectively, in the adynamic cardiomyoplasty group. CONCLUSIONS: Both adynamic cardiomyoplasty and cardiac binding reduced cardiac enlargement and functional deterioration after rapid pacing, with adynamic cardiomyoplasty appearing to be more effective, perhaps because of the adaptive capabilities of the skeletal muscle wrap. However, cardiac binding is a simpler and less invasive procedure, which may be useful as an adjunct to prevent or delay progressive ventricular dilatation in heart failure.


Subject(s)
Cardiomyopathy, Dilated/surgery , Cardiomyoplasty/methods , Heart Ventricles/surgery , Membranes, Artificial , Animals , Cardiac Output , Cardiomyopathy, Dilated/diagnostic imaging , Cardiomyopathy, Dilated/physiopathology , Constriction , Disease Models, Animal , Dogs , Echocardiography , Heart Ventricles/diagnostic imaging , Heart Ventricles/physiopathology , Myocardial Contraction , Prosthesis Design , Random Allocation , Treatment Outcome , Ventricular Function, Left
12.
Ann Thorac Surg ; 65(4): 999-1002, 1998 Apr.
Article in English | MEDLINE | ID: mdl-9564917

ABSTRACT

BACKGROUND: Reexploration of the mediastinum for bleeding is required in 3% to 7% of patients after cardiac operation, with many proving to have no surgically correctable cause. In spite of a "negative exploration," the bleeding often ceases. We propose the hypothesis that such a negative exploration can be therapeutic by reducing marked fibrinolytic activity in the mediastinal cavity. METHODS: Fibrinolytic activity in shed mediastinal blood was compared with that in the system blood in 5 patients after cardiac operation by measuring fibrinogen, fibrin degradation product, plasminogen activator inhibitor-1, and alpha2-antiplasmin levels. RESULTS: Fibrinolytic activity in mediastinal blood was markedly increased when compared with paired systemic venous blood. This was indicated by the mediastinal blood's lower fibrinogen levels (0.47 versus 1.91 U/mL; p < 0.001), very high levels of fibrin degradation products (1,350 versus 200 ng/mL; p < 0.05), and higher levels of plasminogen activator inhibitor-1 (55.5 versus 28.1 ng/mL; p < 0.005). Decreased levels of alpha2-antiplasmin were also observed in the mediastinum (0.50 versus 0.61 U/mL; p < 0.05). CONCLUSIONS: Our data confirm that fibrinolytic activity can be extremely high in the mediastinum in response to clot formation. This may explain the hemostatic effects of a negative reexploration, where irrigation and the removal of clots may reduce the fibrinolytic process; this may allow the bleeding ends of capillaries and small vessels to thrombose. Decreased levels of alpha2-antiplasmin observed suggest that lysine analogs, such as epsilon-aminocaproic acid, may have a beneficial role when locally delivered into the mediastinum.


Subject(s)
Cardiac Surgical Procedures/adverse effects , Mediastinum/surgery , Postoperative Hemorrhage/surgery , Aged , Aminocaproic Acid/administration & dosage , Aminocaproic Acid/therapeutic use , Antifibrinolytic Agents/administration & dosage , Antifibrinolytic Agents/blood , Antifibrinolytic Agents/therapeutic use , Antithrombins/analysis , Aortic Valve/surgery , Blood Coagulation , Capillaries/pathology , Capillaries/physiopathology , Coronary Artery Bypass , Fibrin Fibrinogen Degradation Products/analysis , Fibrinogen/analysis , Fibrinolysis , Fibrinolytic Agents/blood , Hemostasis, Surgical , Hemostatics/administration & dosage , Hemostatics/therapeutic use , Humans , Lysine/administration & dosage , Lysine/analogs & derivatives , Lysine/therapeutic use , Microcirculation/pathology , Microcirculation/physiopathology , Mitral Valve/surgery , Plasminogen Activator Inhibitor 1/blood , Reoperation , Serine Proteinase Inhibitors/blood , Therapeutic Irrigation , alpha-2-Antiplasmin/analysis
13.
Ann Thorac Surg ; 65(4): 1039-44; discussion 1044-5, 1998 Apr.
Article in English | MEDLINE | ID: mdl-9564924

ABSTRACT

BACKGROUND: The apparent paradox seen in patients who have undergone dynamic cardiomyoplasty and shown substantial clinical and functional improvements with only modest hemodynamic changes may be due to inappropriate end points chosen for study, a result of incomplete understanding of mechanisms involved. The purpose of this study was to compare the relative role of the passive "girdling effect" and the dynamic "systolic squeezing effect" of the wrapped muscle in cardiomyoplasty. METHODS: The control group of 6 dogs underwent 4 weeks of rapid pacing (250 beats/min) to induce severe heart failure followed by 8 weeks of observation without rapid pacing. The trajectory of recovery in hemodynamics and cardiac dimensions was followed with echocardiography and Swan-Ganz catheters. In the "adynamic" cardiomyoplasty group (n=4), the left latissimus dorsi muscle was wrapped around the ventricles and allowed to stabilize and mature for 4 weeks. This was followed by rapid pacing and recovery as in the control group. In the "dynamic" cardiomyoplasty group (n=3), the same protocol for the adynamic group was followed except that a synchronizable cardiomyostimulator was attached to the thoracodorsal nerve of the muscle wrap. This allowed the latter to be transformed during the rapid-pacing phase and permitted dynamic squeezing of the muscle wrap to be generated by burst stimulation synchronized with cardiac contraction in a 1:2 ratio. RESULTS: Baseline data were comparable in all groups prior to rapid pacing. After 4 weeks of rapid pacing, the left ventricular ejection fraction was higher in the adynamic (27.0%+/-3.9%; p < 0.05) and dynamic (33.3%+/-2.3%; p < 0.02) cardiomyoplasty groups compared with controls (18.8%+/-8.3%). Similarly, ventricular dilatation in both systole and diastole was less in the adynamic (51.8+/-8.7 mL, [p < 0.002] and 38.2+/-7.2 mL [p < 0.001], respectively) and dynamic (62.0+/-7.2 [p < 0.02] and 41.3+/-3.5 mL [p < 0.005], respectively) cardiomyoplasty groups compared with controls. In the dynamic group, on and off studies were carried out after cessation of rapid pacing while the heart was still in severe failure, and they demonstrated a systolic squeezing effect in stimulated beats. Only this group recovered fully to baseline after 8 weeks. CONCLUSIONS: By reducing myocardial stress, both the passive girdling effect and the dynamic systolic squeezing effect have complementary roles in the mechanisms of dynamic cardiomyoplasty.


Subject(s)
Cardiomyoplasty , Animals , Blood Pressure/physiology , Cardiac Output/physiology , Cardiac Pacing, Artificial , Cardiac Volume/physiology , Cardiomyoplasty/classification , Cardiomyoplasty/methods , Catheterization, Swan-Ganz , Central Venous Pressure/physiology , Diastole , Dilatation, Pathologic/pathology , Dilatation, Pathologic/physiopathology , Dogs , Echocardiography , Electric Stimulation , Heart/physiopathology , Heart Diseases/diagnostic imaging , Heart Diseases/pathology , Heart Diseases/physiopathology , Heart Failure/diagnostic imaging , Heart Failure/physiopathology , Heart Failure/surgery , Heart Rate/physiology , Heart Ventricles/pathology , Heart Ventricles/physiopathology , Myocardial Contraction/physiology , Pulmonary Wedge Pressure/physiology , Skeletal Muscle Ventricle/classification , Skeletal Muscle Ventricle/physiology , Stroke Volume/physiology , Systole , Ventricular Function, Left/physiology , Ventricular Function, Right/physiology , Ventricular Pressure/physiology
15.
J Card Surg ; 13(4): 260-5, 1998 Jul.
Article in English | MEDLINE | ID: mdl-10225181

ABSTRACT

BACKGROUND: Acute ascending aortic dissection is a surgical emergency that requires expeditious diagnosis and prompt surgical intervention. In many centers, transesophageal echocardiography (TEE) is the test of choice on which surgical decisions are based. Echocardiographic false-positive diagnoses are rare but can occur with potentially severe consequences. CASE REPORT: Two clinical cases where ascending aortic dissections were falsely diagnosed by TEE are presented. DISCUSSION: Recent literature comparing the diagnostic accuracy of TEE and other imaging techniques are reviewed. Anatomical limitations of TEE and potential causes of false-positive results are discussed. Multiplane probe reduces, but does not eliminate, the occurrence of false-positive findings. To improve diagnostic specificity without undue delays in the course of clinical decision making, we recommend dividing positive TEE findings into "definite" and "probable" categories. Such subclassification is helpful in identifying cases where additional confirmatory tests are desirable in situations of uncertain diagnosis.


Subject(s)
Aortic Aneurysm/diagnostic imaging , Aortic Dissection/diagnostic imaging , Echocardiography, Transesophageal , Adult , Aortic Dissection/surgery , Aorta, Thoracic/diagnostic imaging , Aortic Aneurysm/surgery , Aortic Aneurysm, Abdominal/diagnostic imaging , Aortic Aneurysm, Abdominal/surgery , Aortography , Decision Making , Diagnosis, Differential , Echocardiography, Transesophageal/classification , False Positive Reactions , Humans , Male , Middle Aged , Patient Care Planning , Sensitivity and Specificity
16.
J Heart Lung Transplant ; 16(10): 1018-25, 1997 Oct.
Article in English | MEDLINE | ID: mdl-9361244

ABSTRACT

BACKGROUND: Dynamic cardiomyoplasty is an evolving treatment for heart failure that uses an electrically stimulated latissimus dorsi muscle wrapped around the heart to improve cardiac function. Preoperative patient characteristics and deaths after cardiomyoplasty have been recorded during the past 5 years in a cumulative database representing worldwide experience of 42 medical centers. METHODS: Statistical models of hazards (monthly death rates) were used to identify risk factors for transiently increased risk of cardiovascular mortality within 2 months after cardiomyoplasty. RESULTS: Actuarial survival (n = 261) was 88%, 80%, and 76% at 1, 3, and 6 months after cardiomyoplasty, respectively. The peak hazard of 6% dying per month occurred during the first month after the surgical procedure. Lower ejection fraction, increased number of major coronary arteries with > or = 70% stenotic lesions, and lower chronotropic responses during exercise were independent risk factors for the transient increase in early cardiovascular mortality. Early risk of cardiovascular mortality was significantly reduced as centers gained experience with more than 3 patients. CONCLUSION: Early survival after cardiomyoplasty has improved with experience and might be reduced further by preoperative assessments that identify patients at highest risk.


Subject(s)
Cardiomyoplasty/mortality , Actuarial Analysis , Cause of Death , Coronary Disease/epidemiology , Databases as Topic , Female , Follow-Up Studies , Heart Failure/surgery , Heart Rate/physiology , Humans , Likelihood Functions , Male , Middle Aged , Multivariate Analysis , Oxygen Consumption/physiology , Physical Exertion/physiology , Proportional Hazards Models , Retrospective Studies , Risk Assessment , Risk Factors , Stroke Volume/physiology , Survival Rate , Time Factors , Ventricular Function, Left/physiology
17.
ASAIO J ; 43(5): M651-7, 1997.
Article in English | MEDLINE | ID: mdl-9360126

ABSTRACT

The development of long term cardiac assist devices is currently limited by the lack of an appropriate totally implantable power source. Transformed fatigue resistant skeletal muscle has been proposed as such a power source. The goal of this study was to determine the optimal latissimus dorsi muscle (LDM) configuration capable of obtaining maximum power output. Four separate in situ configurations were prepared: a latex compliance chamber placed between the LDM and chest wall (Sub-Dorsi), a chamber wrapped in a skeletal muscle ventricle (Circular), linear measurements from the thoracolumbar origin (Linear Origin), and linear measurements from the humeral insertion (Linear Insertion). A device was designed to measure the power output from each configuration in watts per kilogram of muscle. Eight LDMs were acutely studied at varying levels of pre-load. Performance characteristics were measured in each configuration. Peak power outputs were as follows: Sub-Dorsi: 8.3 +/- 1.6 W/kg at 50 cc or 11.6 N pre-load; Circular: 16.4 +/- 6.2 W/kg at 50 cc or 16.9 N; Linear Origin: 47.1 +/- 4.4 W/kg at 23.4 N; and Linear Insertion generated 59.9 +/- 12.1 W/kg at 26 N. Analysis of variance comparison revealed a significance of p < 0.0001. A linear oriented LDM is capable of generating maximal power output. Confirmation of these findings in transformed, conformed, fatigue resistant muscle will provide important performance information essential for the optimal design of implantable muscle powered ventricular assist systems.


Subject(s)
Skeletal Muscle Ventricle , Animals , Biomechanical Phenomena , Biomedical Engineering , Electronics, Medical , Evaluation Studies as Topic , Humans , Pressure , Skeletal Muscle Ventricle/pathology , Skeletal Muscle Ventricle/physiology
18.
J Heart Lung Transplant ; 16(6): 585-95, 1997 Jun.
Article in English | MEDLINE | ID: mdl-9229287

ABSTRACT

BACKGROUND: We hypothesize that the integrity of the latissimus dorsi muscle graft used to wrap the heart may affect the clinical outcome of patients undergoing dynamic cardiomyoplasty. METHODS: By correlating the pathologic findings with their clinical course in five patients who died 1 month to 6 years after dynamic cardiomyoplasty operation, we sought to discern findings that might shed light on the pathophysiology of cardiomyoplasty. RESULTS: Of the two patients who had a limited clinical response, one had an atrophic, edematous latissimus dorsi muscle with fatty infiltration resulting from cardiac cachexia, and the other had insufficient length of latissimus dorsi muscle to cover a large heart. The remaining patients responded well clinically without signs of pump failure and died at various intervals, mostly of arrhythmias. Autopsy findings included the following: (1) one patient with ischemic cardiomyopathy as the underlying disease had development of rich vascularity in the interface between the muscle wrap and the epicardium; whereas in four others with idiopathic cardiomyopathy, such evidence of collateralization was far less evident. (2) There was a variation in the skeletal muscle transformation achieved, with the fraction type I fatigue-resistant fiber in the muscle wrap ranging from 60% to 100%, in spite of the identical transformation protocol used. Such variation is believed to be genetically based. (3) In one patient, the skeletal muscle was paced to contract at 30 to 50 times/minute (2:1 ratio) for more than 5 years. Nevertheless, the pathologic specimen of the muscle wrap showed only minimal interstitial fibrosis. (4) Relatively thin muscle wrap around the heart found at autopsy could be atrophy but most likely was related to muscle transformation, which is known to reduce muscle mass and increase capillary density. (5) All skeletal muscle grafts showed geometric conformation to the shape of the epicardium and grossly looked as if they were an additional layer of the ventricular wall. Such conformation may facilitate the modulation of the ventricular remodelling process in the failing heart, as has been described both in clinical and experimental studies. CONCLUSIONS: Our findings are consistent with and support a number of mechanisms proposed for cardiomyoplasty. Thus preservation of latissimus dorsi muscle graft integrity may be important in the success of dynamic cardiomyoplasty.


Subject(s)
Cardiomyoplasty , Heart Failure/pathology , Muscle, Skeletal/pathology , Myocardium/pathology , Postoperative Complications/pathology , Adult , Atrophy , Cachexia/pathology , Cardiac Output, Low/pathology , Cardiac Output, Low/surgery , Cardiomegaly/pathology , Cardiomegaly/surgery , Cardiomyopathy, Dilated/pathology , Cardiomyopathy, Dilated/surgery , Cause of Death , Collateral Circulation/physiology , Coronary Vessels/pathology , Endocardium/pathology , Heart Failure/surgery , Heart Ventricles/pathology , Humans , Male , Middle Aged , Muscle, Skeletal/blood supply , Muscle, Skeletal/transplantation , Myocardial Ischemia/pathology , Myocardial Ischemia/surgery , Neovascularization, Pathologic/pathology , Ventricular Function, Left/physiology
19.
Nihon Kyobu Geka Gakkai Zasshi ; 45(1): 42-5, 1997 Jan.
Article in Japanese | MEDLINE | ID: mdl-9028122

ABSTRACT

Six dogs were rapidly paced for 4 weeks with a VVI pacemaker, and observed for 4 to 6 weeks after cessation of rapid pacing. Echocardiographic study revealed congestive heart failure at the end of rapid pacing associated with enlarged left ventricles and reduced left ventricular ejection fraction. Four weeks after cessation of rapid pacing, the left ventricular cavity and ejection fraction improved, but did not return to the normal pre-paced values. Six weeks after the cessation, cardiac function recovered, and pathological study of the resected hearts demonstrated normal myocardium without fibrotic or ischemic changes.


Subject(s)
Heart Failure/pathology , Heart Failure/physiopathology , Myocardium/pathology , Animals , Cardiac Pacing, Artificial , Disease Models, Animal , Dogs , Heart Failure/etiology , Stroke Volume , Systole , Ventricular Function, Left
20.
J Card Surg ; 12(5): 354-9, 1997.
Article in English | MEDLINE | ID: mdl-9635274

ABSTRACT

Dynamic cardiomyoplasty (DCM) involves the electrical stimulation of a pedicled latissimus dorsi muscle flap wrapped around the falling ventricle as a means of cardiac assist. To further elucidate a potential neurohumoral mechanism for improvement of cardiac output after myoplasty, we evaluated the hemodynamic effects of in situ stimulation of the latissimus dorsi muscle (in the absence of cardiomyoplasty). In seven mongrel dogs, a nerve cuff electrode (Medtronic 6901) was placed around the left thoracodorsal nerve (TDN). This was attached to a pulse generator (Medtronic, Itrel 7420), delivering a 4.0 volt, 0.19 second on, 0.81 second off, 33 Hz, 210 microsecond pulse width, cyclic bursts similar to that used in DCM. Stroke volume index (SVI) and other hemodynamic parameters as well as plasma norepinephrine (NE) levels were measured at five stages: baseline, stimulator on at 0, 2, and 5 minutes, and stimulator off at 30 minutes after. The animals were then subjected to 4 weeks of rapid pacing at 240 beats/min (Medtronic 8329) to induce heart failure, and as the rapid pacing was discontinued, measurements were repeated as above. After rapid pacing, cardiac function was significantly depressed, and NE was elevated (133 +/- 69 versus 500 +/- 353 pg/mL, p < 0.05). In the normal hearts, TDN stimulation increased SVI, heart rate, systemic pressure, and NE levels. In heart failure, however, no significant changes in cardiac function and NE levels were noted. In conclusion, our data indicate that in the normal hearts, afferent impulses from TDN stimulation alone may augment cardiac function by means of a neurohumoral effect that is not seen in severe heart failure. The implications of these findings in DCM are discussed.


Subject(s)
Cardiac Output, Low/physiopathology , Cardiac Output, Low/therapy , Cardiomyoplasty , Electric Stimulation Therapy , Hemodynamics , Muscle, Skeletal/physiopathology , Thoracic Nerves , Animals , Cardiac Output, Low/surgery , Disease Models, Animal , Dogs , Muscle, Skeletal/blood supply
SELECTION OF CITATIONS
SEARCH DETAIL
...